Results 11 to 20 of about 56,319 (181)
Molecular Understanding of HIV-1 Latency [PDF]
The introduction of highly active antiretroviral therapy (HAART) has been an important breakthrough in the treatment of HIV-1 infection and has also a powerful tool to upset the equilibrium of viral production and HIV-1 pathogenesis.
W. Abbas, G. Herbein
doaj +4 more sources
HIV-1 Latency in Monocytes/Macrophages [PDF]
Human immunodeficiency virus type 1 (HIV-1) targets CD4+ T cells and cells of the monocyte/macrophage lineage. HIV pathogenesis is characterized by the depletion of T lymphocytes and by the presence of a population of cells in which latency has been ...
Amit Kumar, Wasim Abbas, Georges Herbein
doaj +3 more sources
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo. [PDF]
UNLABELLED: Pharmacologically-induced activation of replication competent proviruses from latency in the presence of antiretroviral treatment (ART) has been proposed as a step towards curing HIV-1 infection.
Brinkmann, C.R. +18 more
core +22 more sources
An Integrated Overview of HIV-1 Latency [PDF]
Despite significant advances in our understanding of HIV, a cure has not been realized for the more than 34 million infected with this virus. HIV is incurable because infected individuals harbor cells where the HIV provirus is integrated into the host’s ...
Ruelas, Debbie S., Greene, Warner C.
core +6 more sources
HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency
HIV-1 infection remains non-curative due to the latent reservoir, primarily a small pool of resting memory CD4+ T cells bearing replication-competent provirus.
Raquel Crespo +4 more
doaj +4 more sources
A Canadian Survey of Research on HIV-1 Latency-Where Are We Now and Where Are We Heading? [PDF]
Worldwide, almost 40 million people are currently living with HIV-1. The implementation of cART inhibits HIV-1 replication and reduces viremia but fails to eliminate HIV-1 from latently infected cells.
Abdalla AL +2 more
europepmc +2 more sources
HIV-1 latency reversal agent boosting is not limited by opioid use. [PDF]
Opioid use may affect the HIV-1 reservoir and its reversal from latency. We studied 47 virally suppressed people with HIV (PWH) and observed that lower concentration of HIV-1 latency reversal agents (LRAs), used with small molecules that did not reverse ...
Lilie T +11 more
europepmc +2 more sources
Galectin-1 promotes HIV-1 latency reactivation
J. Rubione +13 more
doaj +2 more sources
The main obstacle to cure HIV-1 is the latent reservoir. Antiretroviral therapy effectively controls viral replication, however, it does not eradicate the latent reservoir. Latent CD4+ T cells are extremely rare in HIV-1 infected patients, making primary
Anne Inderbitzin +9 more
doaj +1 more source
Human immunodeficiency virus type 1 (HIV-1) cannot be completely eliminated because of existence of the latent HIV-1 reservoir. However, the facts of HIV-1 latency, including its establishment and maintenance, are incomplete.
Xinyi Yang +25 more
doaj +1 more source

